These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Nevada
|
26-3439095
|
|
|
(State or Other Jurisdiction of
|
(I.R.S. Employer
|
|
|
Incorporation or Organization)
|
Identification No.)
|
|
Large accelerated filer
|
[ ]
|
Accelerated filer
|
[ ]
|
|
|
Non-accelerated filer
|
[ ]
|
Smaller reporting company
|
[X]
|
|
Page
|
|||
|
Part I
|
Financial Information
|
||
|
Item 1.
|
1
|
||
|
1
|
|||
|
2
|
|||
| 3 | |||
|
4
|
|||
|
5
|
|||
|
Item 2.
|
29
|
||
|
Item 3.
|
34
|
||
|
Item 4.
|
34
|
||
|
Part II
|
Other Information
|
||
|
Item 5.
|
35
|
||
|
Item 6.
|
36
|
||
|
March 31, 2013
|
December 31, 2012
|
|||||||
|
ASSETS
|
(Unaudited)
|
(Audited)
|
||||||
|
Current assets
|
||||||||
|
Cash
|
$ | 44,182 | $ | 363 | ||||
|
Accounts receivable, net of allowance for doubtful
accounts of $33,102 and $44,700, respectively
|
211,278 | 414,671 | ||||||
|
Acquisition deposit
|
195,630 | - | ||||||
|
Other current assets
|
89,234 | 30,009 | ||||||
|
Total current assets
|
540,324 | 445,043 | ||||||
|
Equipment, net
|
12,255 | 14,111 | ||||||
|
Goodwill
|
2,259,624 | 2,259,624 | ||||||
|
Intangible assets, net
|
412,155 | 444,112 | ||||||
|
Other assets
|
33,800 | 187,117 | ||||||
|
TOTAL ASSETS
|
$ | 3,258,158 | $ | 3,350,007 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts payable
|
$ | 608,114 | $ | 514,949 | ||||
|
Accrued interest
|
429,399 | 321,368 | ||||||
|
Accrued and deferred personnel compensation
|
274,929 | 299,534 | ||||||
|
Deferred revenue - related party
|
35,262 | 35,262 | ||||||
|
Deferred revenue and customer deposits
|
187,054 | 181,731 | ||||||
|
Convertible notes payable, net of discount
|
4,237,633 | 2,857,669 | ||||||
|
Notes payable
|
171,984 | 171,984 | ||||||
|
Derivative liabilities
|
4,194,373 | 3,074,504 | ||||||
|
Other current liabilities
|
112,246 | 250,144 | ||||||
|
Earn-out payable
|
- | 2,032,881 | ||||||
|
Total current liabilities
|
10,250,994 | 9,740,026 | ||||||
|
Commitments and Contingencies (See Note 9)
|
||||||||
|
Stockholders' equity (deficit)
|
||||||||
|
Common stock, $0.001 par value; 150,000,000 shares authorized;
23,218,117 and 23,218,117 shares issued and outstanding
as of March 31, 2013 and December 31, 2012, respectively
|
23,218 | 23,218 | ||||||
|
Common stock payable
|
1,711,490 | - | ||||||
|
Additional paid-in capital
|
25,521,840 | 25,412,932 | ||||||
|
Accumulated deficit
|
(34,249,384 | ) | (31,826,169 | ) | ||||
|
Total stockholders' equity (deficit)
|
(6,992,836 | ) | (6,390,019 | ) | ||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
$ | 3,258,158 | $ | 3,350,007 | ||||
|
Three months ended
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Revenues
|
||||||||
|
Revenues
|
$ | 1,027,993 | $ | 1,013,206 | ||||
|
Cost of revenues
|
284,622 | 367,769 | ||||||
|
Gross margin
|
743,371 | 645,437 | ||||||
|
Operating expenses
|
||||||||
|
General and administrative
|
532,628 | 917,582 | ||||||
|
Sales and marketing
|
362,896 | 347,251 | ||||||
|
Engineering, research, and development
|
94,055 | 160,213 | ||||||
|
Depreciation and amortization
|
33,813 | 154,617 | ||||||
|
Total operating expenses
|
1,023,392 | 1,579,663 | ||||||
|
Loss from operations
|
(280,021 | ) | (934,226 | ) | ||||
|
Other income/(expense)
|
||||||||
|
Interest income
|
3 | - | ||||||
|
Interest expense
|
(1,447,359 | ) | (358,178 | ) | ||||
|
Change in fair value of derivative liabilities
|
(1,001,550 | ) | (460,487 | ) | ||||
|
Gain on adjustment in contingent consideration
|
305,712 | 60,651 | ||||||
|
Total other income/(expense)
|
(2,143,194 | ) | (758,014 | ) | ||||
|
Loss before income taxes
|
(2,423,215 | ) | (1,692,240 | ) | ||||
|
Income tax expense
|
- | - | ||||||
|
Net loss
|
$ | (2,423,215 | ) | $ | (1,692,240 | ) | ||
|
Net loss per share - basic and diluted
|
$ | (0.10 | ) | $ | (0.07 | ) | ||
|
Weighted average number of shares
during the period - basic and diluted
|
23,218,117 | 22,797,641 | ||||||
|
Three months ended
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
OPERATING ACTIVITIES
|
||||||||
|
Net loss
|
$ | (2,423,215 | ) | $ | (1,692,240 | ) | ||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Bad debt expense
|
(12,772 | ) | 46,384 | |||||
|
Common stock issued for services
|
- | 270,000 | ||||||
|
Stock-based compensation
|
93,502 | 113,861 | ||||||
|
Depreciation and amortization expense
|
33,813 | 154,617 | ||||||
|
Gain on adjustment in contingent consideration
|
(305,712 | ) | (60,650 | ) | ||||
|
Change in fair value of derivative liabilities
|
1,001,550 | 460,487 | ||||||
|
Amortization of deferred financing costs
|
- | 35,154 | ||||||
|
Amortization of note discounts
|
1,334,729 | 277,349 | ||||||
|
Increase (decrease) in cash resulting from changes in:
|
||||||||
|
Accounts receivable
|
216,165 | (29,797 | ) | |||||
|
Other current assets
|
(59,225 | ) | (324,119 | ) | ||||
|
Other assets
|
- | 2,939 | ||||||
|
Accounts payable
|
93,165 | 225,636 | ||||||
|
Accrued interest
|
108,031 | 41,740 | ||||||
|
Accrued and deferred personnel compensation
|
(24,605 | ) | 106,077 | |||||
|
Deferred revenue - related party
|
- | (33,000 | ) | |||||
|
Deferred revenue and customer deposits
|
5,323 | 9,912 | ||||||
|
Other liabilities
|
(260 | ) | 67,303 | |||||
|
Net cash provided by (used in) operating activities
|
60,489 | (328,347 | ) | |||||
|
INVESTING ACTIVITIES
|
||||||||
|
Purchases of equipment
|
- | (5,515 | ) | |||||
|
Acquisition deposit
|
(195,630 | ) | - | |||||
|
Net cash used in investing activities
|
(195,630 | ) | (5,515 | ) | ||||
|
FINANCING ACTIVITIES
|
||||||||
|
Proceeds from issuance of notes payable, net of finance offering costs
|
200,000 | 585,100 | ||||||
|
Payments on notes payable
|
(21,040 | ) | (188,894 | ) | ||||
|
Payments on cash payment obligation
|
- | (62,500 | ) | |||||
|
Net cash provided by financing activities
|
178,960 | 333,706 | ||||||
|
Net change in cash
|
43,819 | (156 | ) | |||||
|
Cash at beginning of period
|
363 | 396 | ||||||
|
Cash at end of period
|
$ | 44,182 | $ | 240 | ||||
|
Supplemental disclosures:
|
||||||||
|
Cash paid during period for :
|
||||||||
|
Interest
|
$ | 3,960 | $ | 4,835 | ||||
|
Non-cash investing and financing activities:
|
||||||||
|
Note discount
|
$ | 133,725 | $ | 320,557 | ||||
|
Adjustment to derivative liability due to note repayment
|
$ | 15,406 | $ | 49,728 | ||||
|
Common stock payable recorded for earn out payment related to the Boomtext acquisition
|
$ | 1,711,490 | $ | - | ||||
|
Settlement of working capital asset related to the Boomtext acquisition
|
$ | 153,317 | $ | - | ||||
|
Description
|
Level 1
|
Level 2
|
Level 3
|
Gains (Losses)
|
||||||||||||
|
Goodwill (non-recurring)
|
$ | - | $ | - | $ | 2,259,624 | $ | - | ||||||||
|
Intangibles, net (non-recurring)
|
$ | - | $ | - | $ | 412,155 | $ | - | ||||||||
|
Derivatives (recurring)
|
$ | - | $ | - | $ | 4,194,373 | $ | (1,001,550 | ) | |||||||
|
Description
|
Level 1
|
Level 2
|
Level 3
|
Gains (Losses)
|
||||||||||||
|
Goodwill (non-recurring)
|
$ | - | $ | - | $ | 2,259,624 | $ | (742,446 | ) | |||||||
|
Intangibles, net (non-recurring)
|
$ | - | $ | - | $ | 444,112 | $ | (145,396 | ) | |||||||
|
Derivatives (recurring)
|
$ | - | $ | - | $ | 3,074,504 | $ | 359,530 | ||||||||
|
March 31, 2013
|
December 31, 2012
|
|||||||
|
Equipment
|
$ | 155,716 | $ | 155,716 | ||||
|
Furniture and Fixtures
|
14,569 | 14,569 | ||||||
|
Subtotal
|
170,285 | 170,285 | ||||||
|
Less accumulated depreciation
|
(158,030 | ) | (156,174 | ) | ||||
|
Total
|
$ | 12,255 | $ | 14,111 | ||||
|
Balance at
|
Balance at
|
|||||||||||
|
December 31, 2012
|
Amortization
|
March 31, 2013
|
||||||||||
|
Patents and trademarks
|
$ | 111,620 | $ | (2,099 | ) | $ | 109,521 | |||||
|
Customer contracts
|
78,765 | (6,059 | ) | 72,706 | ||||||||
|
Customer relationships
|
29,056 | (7,264 | ) | 21,792 | ||||||||
|
Trade name
|
30,588 | (2,353 | ) | 28,235 | ||||||||
|
Technology / IP
|
193,458 | (13,557 | ) | 179,901 | ||||||||
|
Non-compete
|
625 | (625 | ) | - | ||||||||
| $ | 444,112 | $ | (31,957 | ) | $ | 412,155 | ||||||
|
Year ending December 31,
|
Amount
|
|||
|
2013
|
$ | 93,999 | ||
|
2014
|
96,275 | |||
|
2015
|
96,275 | |||
|
2016
|
47,570 | |||
|
2017
|
8,396 | |||
|
Thereafter
|
69,640 | |||
|
Total
|
$ | 412,155 | ||
|
Derivative Value by Instrument Type
|
March 31, 2013
|
December 31, 2012
|
||||||
|
Convertible Bridge Notes
|
$ | 3,911,699 | $ | 2,850,085 | ||||
|
Common Stock and Warrants
|
154,342 | 129,378 | ||||||
|
Non-employee Warrants
|
128,332 | 95,041 | ||||||
| $ | 4,194,373 | $ | 3,074,504 | |||||
|
Total
|
||||
|
Balance December 31, 2011
|
$ | 1,573,859 | ||
|
Issuances in derivative value due to new security issuances of notes
|
5,352,404 | |||
|
Issuances in derivative value due to allonges
|
118,633 | |||
|
Issuances in derivative value due to vesting of non-employee warrants
|
485,700 | |||
|
Adjustment to derivative liability due to note repayment
|
(167,827 | ) | ||
|
Adjustment to derivative liability due to note conversion
|
(3,323,084 | ) | ||
|
Adjustment to derivative liability due to warrant expiration
|
(1,318 | ) | ||
|
Change in fair value of derivative liabilities
|
(963,863 | ) | ||
|
Balance December 31, 2012
|
3,074,504 | |||
|
Issuances in derivative value due to new security issuances of notes
|
133,725 | |||
|
Issuances in derivative value due to vesting of non-employee warrants
|
12,581 | |||
|
Adjustment to derivative liability due to note repayment
|
(15,406 | ) | ||
|
Change in fair value of derivative liabilities
|
988,969 | |||
|
Balance March 31, 2013
|
$ | 4,194,373 | ||
|
March 31, 2013
|
December 31, 2012
|
|||||||
|
Bridge notes payable
|
$ | 4,521,378 | $ | 4,342,418 | ||||
|
Less unamortized discounts:
|
||||||||
|
VMCO
|
(84,547 | ) | (481,390 | ) | ||||
|
ASID
|
(199,198 | ) | (1,003,359 | ) | ||||
|
Bridge notes payable, net of discounts
|
$ | 4,237,633 | $ | 2,857,669 | ||||
|
●
|
five year warrants to purchase that number of shares of common stock equal to the new Principal Amount plus all accrued and unpaid interest divided by the per share purchase price of the common stock offered and sold in the new Qualifying Financing (the “Offering Price”) which warrants shall be exercisable at the Offering Price and shall include cashless exercise provisions commencing 18 months from the date of issuance of the warrants if there is not at that time an effective registration statement covering the shares of common stock exercisable upon exercise of the warrants, or
|
|
●
|
that number of shares of common stock equal to the product arrived at by multiplying (x) the new Principal Amount plus all accrued and unpaid interest divided by the Offering Price and (y) 0.33.
|
|
VMCO
|
ASID
|
Total
|
||||||||||
|
December 31, 2011
|
$ | (12,031 | ) | $ | (47,739 | ) | $ | (59,770 | ) | |||
|
Additions
|
(1,409,797 | ) | (3,942,607 | ) | (5,352,404 | ) | ||||||
|
Amortization
|
940,438 | 2,986,987 | 3,927,425 | |||||||||
|
December 31, 2012
|
(481,390 | ) | (1,003,359 | ) | (1,484,749 | ) | ||||||
|
Additions
|
(29,451 | ) | (104,274 | ) | (133,725 | ) | ||||||
|
Amortization
|
426,294 | 908,435 | 1,334,729 | |||||||||
|
March 31, 2013
|
$ | (84,547 | ) | $ | (199,198 | ) | $ | (283,745 | ) | |||
|
Notes Payable
|
Accrued Interest
|
|||||||||||||||
|
March 31, 2013
|
December 31, 2012
|
March 31, 2013
|
December 31, 2012
|
|||||||||||||
|
Bridge notes, net, as discussed above
|
$ | 4,237,633 | $ | 2,857,669 | $ | 364,741 | $ | 261,213 | ||||||||
|
Convertible notes payable, net of discounts
|
4,237,633 | 2,857,669 | 364,741 | 261,213 | ||||||||||||
|
Unsecured (as amended) note payable due to our Company’s former Chief Executive Officer, interest accrues at the rate of 9% compounded annually, all amounts due and payable December 31, 2008. Currently past due.
|
20,000 | 20,000 | 14,530 | 13,775 | ||||||||||||
|
Note payable due to a trust, interest accrues at the rate of 10% per annum, all amounts due and payable December 31, 2006. The Company is negotiating the terms of this note. Currently past due.
|
51,984 | 51,984 | 25,579 | 24,297 | ||||||||||||
|
Digimark, LLC subordinated promissory note, net, as discussed above. Currently past due.
|
100,000 | 100,000 | 24,549 | 22,083 | ||||||||||||
|
Notes payable
|
171,984 | 171,984 | 64,658 | 60,155 | ||||||||||||
|
Totals
|
$ | 4,409,617 | $ | 3,029,653 | $ | 429,399 | $ | 321,368 | ||||||||
|
Three months ended
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Amortization of note discounts
|
$ | 1,334,729 | $ | 277,349 | ||||
|
Amortization of deferred financing costs
|
- | 35,154 | ||||||
|
Other interest expense
|
112,630 | 45,675 | ||||||
| $ | 1,447,359 | $ | 358,178 | |||||
|
Weighted -
|
||||||||||||||||
|
Weighted -
|
Average
|
|||||||||||||||
|
Average
|
Remaining
|
Aggregate
|
||||||||||||||
|
Number
|
Exercise Price
|
Contractual
|
Intrinsic
|
|||||||||||||
|
Outstanding
|
Per Share
|
Life (Years)
|
Value
|
|||||||||||||
|
Outstanding at December 31, 2012
|
1,955,000 | $ | 0.77 | 4.44 | $ | - | ||||||||||
|
Granted
|
375,000 | $ | 0.25 | 4.95 | ||||||||||||
|
Exercised
|
- | $ | - | - | ||||||||||||
|
Canceled/forfeited/expired
|
(67,709 | ) | $ | 1.19 | 3.80 | |||||||||||
|
Outstanding at March 31, 2013
|
2,262,291 | $ | 0.67 | 4.34 | $ | - | ||||||||||
|
Options vested and exercisable at March 31, 2013
|
724,577 | $ | 0.90 | 4.34 | $ | - | ||||||||||
|
Unrecognized expense at March 31, 2013
|
$ | 696,493 | ||||||||||||||
|
Number of Options Vested
|
Fair Value of Options Vested
|
|||||||
|
Fair value of options vested during the three months ended March 31, 2013
|
168,125 | $ | 103,184 | |||||
|
Fair value of options vested during the three months ended March 31, 2012
|
398,636 | $ | 184,839 | |||||
|
Awards Breakdown by Range as at March 31, 2013
|
||||||||||||||||||||||||||
|
Outstanding
|
Vested
|
|||||||||||||||||||||||||
|
Exercise Price
|
Outstanding Stock Options
|
Weighted Average Remaining Contractual Life
|
Weighted Average Outstanding Exercise Price
|
Vested Stock Options
|
Weighted Average Remaining Vested Contractual Life
|
Weighted Average Vested Stock Price
|
||||||||||||||||||||
| $ | 0.25 to $0.69 | 1,747,500 | 4.34 | $ | 0.38 | 421,873 | 2.73 | $ | 0.32 | |||||||||||||||||
| $ | 1.16 to $1.80 | 514,791 | 6.23 | $ | 1.65 | 302,704 | 6.57 | $ | 1.70 | |||||||||||||||||
|
Awards Breakdown by Range as at December 31, 2012
|
||||||||||||||||||||||||||
|
Outstanding
|
Vested
|
|||||||||||||||||||||||||
|
Exercise Price
|
Outstanding Stock Options
|
Weighted Average Remaining Contractual Life
|
Weighted Average Outstanding Exercise Price
|
Vested Stock Options
|
Weighted Average Remaining Vested Contractual Life
|
Weighted Average Vested Stock Price
|
||||||||||||||||||||
| $ | 0.32 to $0.69 | 1,410,000 | 3.71 | $ | 0.43 | 374,997 | 2.98 | $ | 0.32 | |||||||||||||||||
| $ | 1.16 to $1.80 | 545,000 | 6.33 | $ | 1.66 | 181,455 | 6.30 | $ | 1.69 | |||||||||||||||||
|
Stock Option Assumptions for the three months ended March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Expected volatility
|
122.0% | 65.0% | ||||||
|
Risk-free interest rate
|
0.42% to 0.60%
|
0.30% to 0.45%
|
||||||
|
Forfeiture rate
|
16.0% | 0.0% | ||||||
|
Expected dividend rate
|
0.0% | 0.0% | ||||||
|
Expected life (yrs)
|
2.77 to 3.58
|
2.77 to 3.58
|
||||||
|
Weighted Average
|
||||||||
|
Grant Date Fair Value
|
||||||||
|
2013
|
2012
|
|||||||
|
Stock options granted during the three months ended March 31,
|
$ | 0.17 | $ | 0.54 | ||||
|
Stock options vested during the three months ended March 31,
|
$ | 0.61 | $ | 0.45 | ||||
|
Stock options canceled/forfeited/expired during the three months ended March 31,
|
$ | 0.47 | $ | 0.26 | ||||
|
Weighted -
|
||||||||||||||||
|
Weighted -
|
Average
|
|||||||||||||||
|
Average
|
Remaining
|
Aggregate
|
||||||||||||||
|
Number
|
Exercise Price
|
Contractual
|
Intrinsic
|
|||||||||||||
|
Outstanding
|
Per Share
|
Life (Years)
|
Value
|
|||||||||||||
|
Outstanding at December 31, 2012
|
905,000 | $ | 0.33 | 4.10 | $ | - | ||||||||||
|
Granted
|
- | - | - | |||||||||||||
|
Exercised
|
- | - | - | |||||||||||||
|
Canceled/forfeited/expired
|
- | - | - | |||||||||||||
|
Outstanding at March 31, 2013
|
905,000 | 0.33 | 3.85 | $ | - | |||||||||||
|
Warrants vested and exercisable at March 31, 2013
|
679,575 | $ | 0.33 | 3.54 | $ | - | ||||||||||
|
Awards Breakdown by Range as at March 31, 2013
|
||||||||||||||||||||||||||
|
Outstanding
|
Vested
|
|||||||||||||||||||||||||
|
Exercise Price
|
Outstanding Warrants
|
Weighted Average Remaining Contractual Life
|
Weighted Average Outstanding Exercise Price
|
Vested Warrants
|
Weighted Average Remaining Vested Contractual Life
|
Weighted Average Vested Stock Price
|
||||||||||||||||||||
| $ | 0.32 | 900,000 | 3.86 | $ | 0.32 | 677,076 | 3.54 | $ | 0.32 | |||||||||||||||||
| $ | 1.75 | 5,000 | 3.27 | $ | 1.75 | 2,499 | 3.27 | $ | 1.75 | |||||||||||||||||
|
Outstanding
|
Vested
|
|||||||||||||||||||||||||
|
Exercise Price
|
Outstanding Warrants
|
Weighted Average Remaining Contractual Life
|
Weighted Average Outstanding Exercise Price
|
Vested Warrants
|
Weighted Average Remaining Vested Contractual Life
|
Weighted Average Vested Stock Price
|
||||||||||||||||||||
| $ | 0.32 | 900,000 | 4.10 | $ | 0.32 | 620,827 | 3.76 | $ | 0.32 | |||||||||||||||||
| $ | 1.75 | 5,000 | 3.52 | $ | 1.75 | 2,187 | 3.52 | $ | 1.75 | |||||||||||||||||
|
Minimum Lease Payments
|
||||
|
2013
|
$ | 104,007 | ||
|
2014
|
143,492 | |||
|
2015
|
148,281 | |||
|
2016
|
- | |||
|
2017
|
- | |||
|
Thereafter
|
- | |||
| $ | 395,780 | |||
|
Item
2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
Item
3.
|
Quantitative and Qualitative Disclosures about Market Risk.
|
|
Item 4.
|
Controls and Procedures.
|
|
(1)
|
Inadequate segregation of duties and effective risk assessment;
|
|
|
(2)
|
Insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both generally accepted accounting principles in the United States and guidelines of the SEC; and
|
|
|
(3)
|
Inadequate closing processes to ensure all material misstatements are corrected in the financial statements, as evidenced by the fact that there were audit adjustments and restatements of our financial statements.
|
|
Item
6.
|
Exhibits.
|
|
Exhibit No.
|
Description
|
Method of Filing
|
|
| 10.1 |
Form of Amendment to 10% Senior Secured Convertible Bridge Notes due October 15, 2013
|
Filed as Exhibit 99.1 to Current Report on Form 8-K filed on dated May 10, 2013
|
| 10.2 | Asset Purchase Agreement by and among Mobivity Holdings Corp., Mobivity, Inc. and Sequence LLC |
Filed electronically herewith
|
|
31.1
|
Certification by Chief Executive Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002
|
Filed electronically herewith
|
|
31.2
|
Certification by Chief Financial Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002
|
Filed electronically herewith
|
|
32.1
|
Certification Pursuant to 18 U.S.C. Section 1350
|
Filed electronically herewith
|
|
101.INS
|
XBRL Instance Document*
|
Filed electronically herewith
|
|
101.SCH
|
XBRL Taxonomy Schema Document*
|
Filed electronically herewith
|
|
101.CAL
|
XBRL Taxonomy Calculation Linkbase Document*
|
Filed electronically herewith
|
|
101.DEF
|
XBRL Taxonomy Definition Linkbase Document*
|
Filed electronically herewith
|
|
101.LAB
|
XBRL Taxonomy Label Linkbase Document*
|
Filed electronically herewith
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase Document*
|
Filed electronically herewith
|
|
Mobivity Holdings Corp.
|
||||
|
Date: May 15, 2013
|
By:
|
/s/ Dennis Becker
|
||
|
Dennis Becker
|
||||
|
Chief Executive Officer
|
||||
|
(Principal Executive Officer)
|
||||
|
Date: May 15, 2013
|
By:
|
/s/ Timothy Schatz
|
||
|
Timothy Schatz
|
||||
|
Chief Financial Officer
(Principal Accounting Officer)
|
||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|